Could This Seattle Pot Stock SOAR as Legal Weed Market Expands?
Fifteen states plus the District of Columbia now permit the recreational use of cannabis and Congress is on track to decriminalize marijuana possession on the federal level. As a result, the North American cannabis market is expected to TRIPLE in size from $30 billion to $100 billion by the year 2027 – and one Seattle manufacturer is poised to cash in!
Details in Brand-New Special Report!

NGM Insider Trading (NGM Biopharmaceuticals)

Insider Ownership Percentage: 50.40%
Insider Buying (Last 12 Months): $3,409,280.89
Insider Selling (Last 12 Months): $4,059,000.00

NGM Biopharmaceuticals Insider Trading History Chart

NGM Biopharmaceuticals Share Price & Price History

$20.25
▼ -0.12 (-0.59%)
As of 06/21/2021 03:58 PM ET
Days: 30 | 90 | 365
Could This Seattle Pot Stock SOAR as Legal Weed Market Expands?
Fifteen states plus the District of Columbia now permit the recreational use of cannabis and Congress is on track to decriminalize marijuana possession on the federal level. As a result, the North American cannabis market is expected to TRIPLE in size from $30 billion to $100 billion by the year 2027 – and one Seattle manufacturer is poised to cash in!
Details in Brand-New Special Report!

NGM Biopharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/12/2021Jin-Long ChenInsiderSell25,000$24.65$616,250.00945,005View SEC Filing Icon  
3/1/2021Jin-Long ChenInsiderSell25,000$26.66$666,500.00970,005View SEC Filing Icon  
1/4/2021Jin-Long ChenInsiderSell25,000$29.28$732,000.00870,375View SEC Filing Icon  
12/14/2020Jin-Long ChenInsiderSell25,000$28.01$700,250.00908,879View SEC Filing Icon  
10/12/2020Jin-Long ChenInsiderSell25,000$17.02$425,500.00945,005View SEC Filing Icon  
9/1/2020Group L P ColumnDirectorBuy36,494$17.64$643,754.16View SEC Filing Icon  
9/1/2020Jin-Long ChenInsiderSell25,000$17.83$445,750.00977,618View SEC Filing Icon  
8/27/2020Group L P ColumnDirectorBuy36,359$17.79$646,826.61View SEC Filing Icon  
8/24/2020Group L P ColumnDirectorBuy11,024$17.96$197,991.04View SEC Filing Icon  
8/21/2020Group L P ColumnDirectorBuy7,321$17.97$131,558.37View SEC Filing Icon  
8/17/2020Group L P ColumnDirectorBuy6,425$17.89$114,943.25View SEC Filing Icon  
8/13/2020Group L P ColumnDirectorBuy19,895$17.89$355,921.55View SEC Filing Icon  
7/30/2020Group L P ColumnDirectorBuy732$17.99$13,168.68View SEC Filing Icon  
7/27/2020Group L P ColumnDirectorBuy3,834$17.99$68,973.66View SEC Filing Icon  
7/24/2020Group L P ColumnDirectorBuy68,749$17.93$1,232,669.57View SEC Filing Icon  
7/22/2020Group L P ColumnDirectorBuy193$18.00$3,474.00View SEC Filing Icon  
7/1/2020Jin-Long ChenInsiderSell25,000$18.91$472,750.001,027,268View SEC Filing Icon  
6/15/2020Jin-Long ChenInsiderSell25,000$21.65$541,250.00View SEC Filing Icon  
5/15/2020Hsiao D. LieuSVPSell1,562$22.00$34,364.00View SEC Filing Icon  
4/7/2020Group L P ColumnMajor ShareholderBuy138,315$14.19$1,962,689.85View SEC Filing Icon  
4/7/2020Peter SvennilsonDirectorBuy123,728$14.38$1,779,208.6420,000View SEC Filing Icon  
4/2/2020Group L P ColumnMajor ShareholderBuy250,984$12.78$3,207,575.52View SEC Filing Icon  
4/2/2020Peter SvennilsonDirectorBuy14,850$12.40$184,140.0020,000View SEC Filing Icon  
3/31/2020Peter SvennilsonDirectorBuy118,067$12.53$1,479,379.5120,000View SEC Filing Icon  
3/25/2020Group L P ColumnMajor ShareholderBuy301,180$13.33$4,014,729.40View SEC Filing Icon  
3/25/2020Peter SvennilsonDirectorBuy2,416$12.49$30,175.8420,000View SEC Filing Icon  
3/23/2020Peter SvennilsonDirectorBuy170,387$11.63$1,981,600.8120,000View SEC Filing Icon  
3/20/2020Group L P ColumnMajor ShareholderBuy143,082$11.77$1,684,075.14View SEC Filing Icon  
3/19/2020Peter SvennilsonDirectorBuy148,464$11.59$1,720,697.7620,000View SEC Filing Icon  
3/5/2020Peter SvennilsonDirectorBuy8,307$18.00$149,526.0020,000View SEC Filing Icon  
3/4/2020Group L P ColumnMajor ShareholderBuy9,986$17.96$179,348.56View SEC Filing Icon  
3/3/2020Peter SvennilsonDirectorBuy38,758$17.99$697,256.4220,000View SEC Filing Icon  
3/2/2020Group L P ColumnMajor ShareholderBuy14,124$17.90$252,819.60View SEC Filing Icon  
2/28/2020Group L P ColumnMajor ShareholderBuy75,447$18.04$1,361,063.88View SEC Filing Icon  
2/27/2020Peter SvennilsonDirectorBuy33,896$17.91$607,077.3620,000View SEC Filing Icon  
2/26/2020Group L P ColumnMajor ShareholderBuy3,751$18.00$67,518.00View SEC Filing Icon  
2/6/2020Group L P ColumnMajor ShareholderBuy44,900$15.47$694,603.00View SEC Filing Icon  
1/9/2020Jin-Long ChenInsiderSell18,641$17.95$334,605.951,012,783View SEC Filing Icon  
1/7/2020Jin-Long ChenInsiderSell16,090$18.20$292,838.001,012,783View SEC Filing Icon  
11/11/2019Peter SvennilsonDirectorBuy15$12.00$180.0020,000View SEC Filing Icon  
11/4/2019Jin-Long ChenInsiderSell50,765$12.67$643,192.55
11/4/2019Peter SvennilsonDirectorBuy8,409$13.01$109,401.09
10/23/2019Peter SvennilsonDirectorBuy4,387$13.54$59,399.98
10/21/2019Group L P ColumnMajor ShareholderSell30,926$77.72$2,403,568.72
10/21/2019Peter SvennilsonDirectorBuy84,939$11.75$998,033.25
10/16/2019David V GoeddelDirectorBuy11,000$3.10$34,100.00
10/16/2019Group L P ColumnMajor ShareholderBuy103,000$10.87$1,119,610.00
10/14/2019Group L P ColumnMajor ShareholderSell20,000$1.41$28,200.00
10/11/2019Group L P ColumnMajor ShareholderBuy53,172$10.38$551,925.36
8/9/2019Group L P ColumnMajor ShareholderBuy224,664$14.00$3,145,296.00View SEC Filing Icon  
8/6/2019David V GoeddelDirectorBuy6,134$13.98$85,753.32View SEC Filing Icon  
8/2/2019Group L P ColumnMajor ShareholderBuy4,382$13.98$61,260.36View SEC Filing Icon  
7/30/2019Peter SvennilsonDirectorBuy28,056$13.68$383,806.08View SEC Filing Icon  
7/26/2019David V GoeddelDirectorBuy89,866$13.49$1,212,292.34View SEC Filing Icon  
7/23/2019Group L P ColumnMajor ShareholderBuy67,742$13.49$913,839.58View SEC Filing Icon  
7/16/2019Group L P ColumnMajor ShareholderBuy20,088$13.72$275,607.36View SEC Filing Icon  
7/12/2019Group L P ColumnMajor ShareholderBuy31,884$13.88$442,549.92View SEC Filing Icon  
6/24/2019Group L P ColumnMajor ShareholderBuy12,240$13.78$168,667.20View SEC Filing Icon  
6/21/2019Group L P ColumnMajor ShareholderBuy34,377$13.90$477,840.30View SEC Filing Icon  
6/14/2019Peter SvennilsonDirectorBuy29,760$14.05$418,128.00View SEC Filing Icon  
6/11/2019Group L P ColumnMajor ShareholderBuy23,500$13.74$322,890.00View SEC Filing Icon  
6/6/2019Group L P ColumnMajor ShareholderBuy25,200$13.40$337,680.00View SEC Filing Icon  
5/20/2019Group L P ColumnMajor ShareholderBuy50,000$13.50$675,000.00View SEC Filing Icon  
5/10/2019Group L P ColumnMajor ShareholderBuy17,923$13.85$248,233.55View SEC Filing Icon  
5/7/2019Peter SvennilsonDirectorBuy57,000$14.10$803,700.00View SEC Filing Icon  
4/8/2019Merck & Co., Inc.Major ShareholderBuy4,121,683$16.00$65,946,928.00View SEC Filing Icon  
4/8/2019Suzanne Sawochka HooperDirectorBuy7,000$16.00$112,000.00View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for NGM Biopharmaceuticals (NASDAQ:NGM)

55.87% of NGM Biopharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

NGM Biopharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/24/2021Principal Financial Group Inc.15,291$0.45M0.0%+7.6%0.020%Search for SEC Filing on Google Icon
5/19/2021Octagon Capital Advisors LP200,000$5.81M2.2%+165.9%0.260%Search for SEC Filing on Google Icon
5/19/2021Squarepoint Ops LLC24,039$0.70M0.0%+16.6%0.031%Search for SEC Filing on Google Icon
5/18/2021Baker BROS. Advisors LP291,801$8.48M0.0%+173.7%0.379%Search for SEC Filing on Google Icon
5/18/2021Point72 Asset Management L.P.2,175,000$63.23M0.3%+23.5%2.824%Search for SEC Filing on Google Icon
5/18/2021D. E. Shaw & Co. Inc.10,188$0.30M0.0%N/A0.013%Search for SEC Filing on Google Icon
5/18/2021Verition Fund Management LLC116,726$3.39M0.0%-29.5%0.152%Search for SEC Filing on Google Icon
5/18/2021Morgan Stanley242,570$7.05M0.0%+15.4%0.315%Search for SEC Filing on Google Icon
5/18/2021Redmile Group LLC2,751,815$80M1.1%N/A3.573%Search for SEC Filing on Google Icon
5/18/2021Cubist Systematic Strategies LLC12,751$0.37M0.0%+560.7%0.017%Search for SEC Filing on Google Icon
5/18/2021Euclidean Capital LLC1,493,349$43.41M14.5%-28.3%1.939%Search for SEC Filing on Google Icon
5/18/2021California State Teachers Retirement System38,805$1.13M0.0%+7.6%0.050%Search for SEC Filing on Google Icon
5/17/2021Royal Bank of Canada1,650$48K0.0%N/A0.002%Search for SEC Filing on Google Icon
5/17/2021Rock Springs Capital Management LP364,800$10.61M0.2%+1.2%0.474%Search for SEC Filing on Google Icon
5/17/2021Price T Rowe Associates Inc. MD379,463$11.03M0.0%N/A0.493%Search for SEC Filing on Google Icon
5/17/2021DAFNA Capital Management LLC10,000$0.29M0.1%N/A0.013%Search for SEC Filing on Google Icon
5/17/2021Hennion & Walsh Asset Management Inc.259,841$7.55M0.5%N/A0.337%Search for SEC Filing on Google Icon
5/17/2021Nuveen Asset Management LLC172,676$5.02M0.0%+72.7%0.224%Search for SEC Filing on Google Icon
5/17/2021Goldman Sachs Group Inc.51,381$1.49M0.0%+7.0%0.067%Search for SEC Filing on Google Icon
5/14/2021Dimensional Fund Advisors LP145,264$4.21M0.0%+104.8%0.189%Search for SEC Filing on Google Icon
5/14/2021TD Asset Management Inc.24,500$0.71M0.0%N/A0.032%Search for SEC Filing on Google Icon
5/13/2021SG Americas Securities LLC4,316$0.13M0.0%-84.8%0.006%Search for SEC Filing on Google Icon
5/13/2021Barclays PLC26,569$0.77M0.0%+63.6%0.034%Search for SEC Filing on Google Icon
5/13/2021Bank of New York Mellon Corp79,756$2.32M0.0%-4.1%0.104%Search for SEC Filing on Google Icon
5/13/2021Citigroup Inc.4,321$0.13M0.0%-41.1%0.006%Search for SEC Filing on Google Icon
5/13/2021Aviva PLC42,095$1.22M0.0%N/A0.055%Search for SEC Filing on Google Icon
5/12/2021Northern Trust Corp273,840$7.96M0.0%+1.6%0.356%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC458,313$13.32M0.0%+32.6%0.595%Search for SEC Filing on Google Icon
5/12/2021JPMorgan Chase & Co.175,332$5.10M0.0%-8.7%0.228%Search for SEC Filing on Google Icon
5/12/2021UBS Group AG42,200$1.23M0.0%+130.6%0.055%Search for SEC Filing on Google Icon
5/10/2021Russell Investments Group Ltd.21,822$0.63M0.0%-35.7%0.028%Search for SEC Filing on Google Icon
5/10/2021Principal Financial Group Inc.15,291$0.45M0.0%+7.6%0.020%Search for SEC Filing on Google Icon
5/10/2021Checchi Capital Advisers LLC8,000$0.23M0.0%N/A0.010%Search for SEC Filing on Google Icon
5/7/2021BlackRock Inc.2,764,580$80.37M0.0%+9.5%3.592%Search for SEC Filing on Google Icon
5/7/2021American International Group Inc.14,995$0.44M0.0%+8.2%0.019%Search for SEC Filing on Google Icon
5/7/2021BNP Paribas Arbitrage SA3,434$100K0.0%-24.6%0.004%Search for SEC Filing on Google Icon
5/6/2021Rhumbline Advisers28,492$0.83M0.0%-2.9%0.037%Search for SEC Filing on Google Icon
5/6/2021Alliancebernstein L.P.24,700$0.72M0.0%-17.1%0.032%Search for SEC Filing on Google Icon
5/3/2021Zurcher Kantonalbank Zurich Cantonalbank1,973$57K0.0%N/A0.003%Search for SEC Filing on Google Icon
4/30/2021Exane Derivatives6,539$0.19M0.1%+12.4%0.009%Search for SEC Filing on Google Icon
4/28/2021DekaBank Deutsche Girozentrale47,100$1.30M0.0%+123.2%0.061%Search for SEC Filing on Google Icon
4/23/2021Strs Ohio22,700$0.66M0.0%+48.4%0.030%Search for SEC Filing on Google Icon
3/12/2021DekaBank Deutsche Girozentrale21,100$0.65M0.0%-5.0%0.031%Search for SEC Filing on Google Icon
3/8/2021Dimensional Fund Advisors LP70,932$2.15M0.0%+46.5%0.103%Search for SEC Filing on Google Icon
2/25/2021Dimensional Fund Advisors LP70,932$2.15M0.0%+46.5%0.103%Search for SEC Filing on Google Icon
2/25/2021Hsbc Holdings PLC11,302$0.34M0.0%-26.4%0.016%Search for SEC Filing on Google Icon
2/23/2021Principal Financial Group Inc.14,214$0.43M0.0%-71.0%0.021%Search for SEC Filing on Google Icon
2/19/2021JPMorgan Chase & Co.192,094$5.82M0.0%-5.4%0.278%Search for SEC Filing on Google Icon
2/18/2021Verition Fund Management LLC165,628$5.02M0.0%N/A0.240%Search for SEC Filing on Google Icon
2/17/2021Jane Street Group LLC7,066$0.21M0.0%N/A0.010%Search for SEC Filing on Google Icon
2/17/2021Samsara BioCapital LLC18,225$0.55M0.1%-50.0%0.026%Search for SEC Filing on Google Icon
2/16/2021Squarepoint Ops LLC20,618$0.63M0.0%N/A0.030%Search for SEC Filing on Google Icon
2/16/2021Morgan Stanley210,283$6.37M0.0%+37.4%0.305%Search for SEC Filing on Google Icon
2/16/2021Baker BROS. Advisors LP106,616$3.23M0.0%-9.7%0.154%Search for SEC Filing on Google Icon
2/16/2021Nuveen Asset Management LLC99,980$3.03M0.0%+6.5%0.145%Search for SEC Filing on Google Icon
2/16/2021Engineers Gate Manager LP33,731$1.02M0.0%-23.8%0.049%Search for SEC Filing on Google Icon
2/16/2021Charles Schwab Investment Management Inc.131,499$3.98M0.0%+1.4%0.191%Search for SEC Filing on Google Icon
2/13/2021American International Group Inc.13,861$0.42M0.0%-2.8%0.020%Search for SEC Filing on Google Icon
2/12/2021Penserra Capital Management LLC1,585$48K0.0%+169.6%0.002%Search for SEC Filing on Google Icon
2/12/2021The Manufacturers Life Insurance Company15,518$0.47M0.0%+3.0%0.022%Search for SEC Filing on Google Icon
2/12/2021Virtus ETF Advisers LLC10,685$0.32M0.1%-28.2%0.015%Search for SEC Filing on Google Icon
2/11/2021Northern Trust Corp269,472$8.16M0.0%-2.3%0.390%Search for SEC Filing on Google Icon
2/11/2021Barclays PLC16,238$0.49M0.0%-36.1%0.024%Search for SEC Filing on Google Icon
2/11/2021Citigroup Inc.7,341$0.22M0.0%+40.7%0.011%Search for SEC Filing on Google Icon
2/10/2021Rhumbline Advisers29,352$0.89M0.0%+6.8%0.043%Search for SEC Filing on Google Icon
2/9/2021Wells Fargo & Company MN35,978$1.09M0.0%-29.6%0.052%Search for SEC Filing on Google Icon
2/9/2021Bank of New York Mellon Corp83,155$2.52M0.0%-2.2%0.120%Search for SEC Filing on Google Icon
2/9/2021Princeton Global Asset Management LLC1,600$48K0.0%N/A0.002%Search for SEC Filing on Google Icon
2/9/2021ProShare Advisors LLC15,931$0.48M0.0%+13.7%0.023%Search for SEC Filing on Google Icon
2/8/2021Alliancebernstein L.P.29,800$0.90M0.0%-4.5%0.043%Search for SEC Filing on Google Icon
2/8/2021Beacon Investment Advisory Services Inc.7,071$0.21M0.0%N/A0.010%Search for SEC Filing on Google Icon
2/8/2021Russell Investments Group Ltd.33,962$1.03M0.0%-4.7%0.049%Search for SEC Filing on Google Icon
2/5/2021BlackRock Inc.2,525,616$76.51M0.0%+3.3%3.659%Search for SEC Filing on Google Icon
2/5/2021Aperio Group LLC10,526$0.32M0.0%N/A0.015%Search for SEC Filing on Google Icon
2/5/2021SG Americas Securities LLC28,375$0.86M0.0%+142.5%0.041%Search for SEC Filing on Google Icon
2/4/2021Cambridge Investment Research Advisors Inc.8,306$0.25M0.0%N/A0.012%Search for SEC Filing on Google Icon
2/4/2021GSA Capital Partners LLP46,908$1.42M0.2%N/A0.068%Search for SEC Filing on Google Icon
2/4/2021State of Wisconsin Investment Board33,500$1.02M0.0%-11.1%0.049%Search for SEC Filing on Google Icon
1/27/2021Exane Derivatives5,819$0.18M0.1%N/A0.008%Search for SEC Filing on Google Icon
1/25/2021Nisa Investment Advisors LLC8,099$0.25M0.0%+175.3%0.012%Search for SEC Filing on Google Icon
1/22/2021Candriam Luxembourg S.C.A.221,634$6.72M0.1%-3.1%0.321%Search for SEC Filing on Google Icon
1/21/2021Cutler Group LP2,000$60K0.0%+100.0%0.003%Search for SEC Filing on Google Icon
11/17/2020Voloridge Investment Management LLC10,328$0.16M0.0%-54.3%0.015%Search for SEC Filing on Google Icon
11/17/2020California State Teachers Retirement System35,834$0.57M0.0%+1.2%0.052%Search for SEC Filing on Google Icon
11/16/2020Cubist Systematic Strategies LLC8,748$0.14M0.0%-49.3%0.013%Search for SEC Filing on Google Icon
11/16/2020Point72 Asset Management L.P.1,611,850$25.65M0.1%+5.8%2.342%Search for SEC Filing on Google Icon
11/16/2020Samsara BioCapital LLC36,451$0.58M0.2%-25.0%0.053%Search for SEC Filing on Google Icon
11/16/2020Weld Capital Management LLC15,238$0.24M0.1%N/A0.022%Search for SEC Filing on Google Icon
11/16/2020Engineers Gate Manager LP44,292$0.71M0.0%-23.0%0.064%Search for SEC Filing on Google Icon
11/13/2020Morgan Stanley153,049$2.44M0.0%-17.5%0.222%Search for SEC Filing on Google Icon
11/13/2020Charles Schwab Investment Management Inc.129,660$2.06M0.0%+58.0%0.188%Search for SEC Filing on Google Icon
11/13/2020Virtus ETF Advisers LLC14,880$0.24M0.1%-12.0%0.022%Search for SEC Filing on Google Icon
11/12/2020Quilter Plc12,000$0.19M0.0%-7.7%0.017%Search for SEC Filing on Google Icon
11/12/2020JPMorgan Chase & Co.203,014$3.27M0.0%-7.0%0.295%Search for SEC Filing on Google Icon
11/10/2020State Street Corp441,700$7.03M0.0%-4.9%0.642%Search for SEC Filing on Google Icon
11/9/2020SG Americas Securities LLC11,700$0.19M0.0%-85.8%0.017%Search for SEC Filing on Google Icon
11/6/2020BlackRock Inc.2,444,439$38.89M0.0%+7.0%3.552%Search for SEC Filing on Google Icon
11/5/2020California Public Employees Retirement System53,774$0.86M0.0%+1.5%0.078%Search for SEC Filing on Google Icon
11/5/2020First Trust Advisors LP69,009$1.10M0.0%N/A0.100%Search for SEC Filing on Google Icon
11/5/2020Wells Fargo & Company MN51,113$0.81M0.0%-39.0%0.074%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
NGM Biopharmaceuticals logo
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trials for the treatment of non-alcoholic steatohepatitis (NASH); and MK-3655, an agonistic antibody that activates fibroblast growth factor receptor 1c-beta-klotho, which is in Phase IIb clinical trial for use in the treatment of type 2 diabetes and NASH. Its products under development also comprise NGM120, an inhibitory antibody binding glial cell-derived neurotrophic factor receptor alpha-like that is in Phase Ib clinical trials to inhibit growth differentiation factor GDF15 levels on cancer anorexia/cachexia syndrome; NGM621, an antibody in Phase II clinical trials for the treatment of geographic atrophy; and NGM707 and NGM438, which are in preclinical investigational studies for the treatment of advanced solid tumors. The company has research collaboration, product development, and license agreements with Merck Sharp & Dohme Corp. NGM Biopharmaceuticals, Inc. was incorporated in 2007 and is headquartered in South San Francisco, California.
Read More on NGM Biopharmaceuticals

Today's Range

Now: $20.25
$19.39
$20.36

50 Day Range

MA: $23.21
$15.06
$28.89

52 Week Range

Now: $20.25
$14.90
$32.12

Volume

9,774 shs

Average Volume

358,340 shs

Market Capitalization

$1.56 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2

Who are the company insiders with the largest holdings of NGM Biopharmaceuticals?

NGM Biopharmaceuticals' top insider shareholders include:
  1. Jin-Long Chen (Insider)
  2. Peter Svennilson (Director)
  3. David V Goeddel (Director)
  4. Group L P Column (Director)
  5. Group L P Column (Major Shareholder)
  6. Hsiao D Lieu (SVP)

Who are the major institutional investors of NGM Biopharmaceuticals?

NGM Biopharmaceuticals' top institutional shareholders include:
  1. BlackRock Inc. — 3.59%
  2. Redmile Group LLC — 3.57%
  3. Point72 Asset Management L.P. — 2.82%
  4. Euclidean Capital LLC — 1.94%
  5. Geode Capital Management LLC — 0.60%
  6. Price T Rowe Associates Inc. MD — 0.49%

Which major investors are selling NGM Biopharmaceuticals stock?

During the last quarter, NGM stock was sold by these institutional investors:
  1. Euclidean Capital LLC
  2. Verition Fund Management LLC
  3. SG Americas Securities LLC
  4. JPMorgan Chase & Co.
  5. Russell Investments Group Ltd.
  6. Alliancebernstein L.P.
  7. Bank of New York Mellon Corp
  8. Citigroup Inc.

Which major investors are buying NGM Biopharmaceuticals stock?

During the last quarter, NGM stock was acquired by institutional investors including:
  1. Redmile Group LLC
  2. Point72 Asset Management L.P.
  3. Price T Rowe Associates Inc. MD
  4. Hennion & Walsh Asset Management Inc.
  5. BlackRock Inc.
  6. Baker BROS. Advisors LP
  7. Octagon Capital Advisors LP
  8. Geode Capital Management LLC
Within the last year, these company insiders have bought NGM Biopharmaceuticals stock:
  1. Jin-Long Chen (Insider)
  2. Peter Svennilson (Director)
  3. David V Goeddel (Director)
  4. Group L P Column (Director)
Could This Seattle Pot Stock SOAR as Legal Weed Market Expands?
Fifteen states plus the District of Columbia now permit the recreational use of cannabis and Congress is on track to decriminalize marijuana possession on the federal level. As a result, the North American cannabis market is expected to TRIPLE in size from $30 billion to $100 billion by the year 2027 – and one Seattle manufacturer is poised to cash in!
Details in Brand-New Special Report!